Amelioration of selenite toxicity and cataractogenesis in cultured rat lenses by Vitex negundo.
OBJECTIVE
Recent evidence suggests that oxidative stress plays a significant role in the development of cataract. The present study sought to evaluate the efficacy of flavonoid fraction of Vitex negundo (FVN) in preventing the toxicity induced by sodium selenite in vitro culture condition.


METHODS
Enucleated rat lenses were maintained in organ culture containing DMEM medium alone (G I), supplemented with 0.1mM sodium selenite (G II), sodium selenite + 20 μg/ml quercetin (G III) and sodium selenite + 50 μg/ml FVN (G IV). Treatment was from the second to fifth day, while selenite administration was done on the third day. After the experimental period, lenses were taken out and the activities of superoxide dismutase (SOD), catalase, Ca(2+) ATPase, levels of reduced glutathione (GSH), calcium, reactive oxygen species (ROS), thiobarbituric acid reactive substances (TBARS), and sulfhydryl content were studied.


RESULTS
Morphological examination revealed dense vacuolization and loss of cortical transparency in G II compared to control and treated group. The mean activities of the enzymes SOD, catalase and Ca(2+) ATPase, levels of GSH and sulfhydryl content were significantly reduced in lenses of G II compared to control. In addition, the mean levels of ROS, calcium and TBARS were elevated in G II compared to control. However, these changes were modulated by FVN treatment to further strengthen its protective role over selenite cataract.


CONCLUSIONS
These results suggest that FVN treatment prevented selenite toxicity and cataractogenesis by maintaining antioxidant status, calcium homeostasis, protecting sulfhydryl group, and decreasing oxidative stress in lens, which may be due to its protective effects.
Department of Biochemistry, University of Kerala, Kariavattom, Kerala, India.
B N
BN
Rooban
V
V
Sasikala
V
V
Sahasranamam
Annie
A
Abraham
D000818:Animals; D002118:Calcium / Q000378:metabolism; D000252:Calcium-Transporting ATPases / Q000378:metabolism; D002374:Catalase / Q000378:metabolism; D002386:Cataract / Q000378:metabolism / Q000517:prevention & control*; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use*; D005978:Glutathione / Q000378:metabolism; D007908:Lens, Crystalline / Q000187:drug effects* / Q000378:metabolism; D009924:Organ Culture Techniques; D018384:Oxidative Stress; D008517:Phytotherapy; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species / Q000378:metabolism; D018038:Sodium Selenite / Q000633:toxicity*; D013482:Superoxide Dismutase / Q000378:metabolism; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism; D020950:Vitex / Q000737:chemistry*
D005419:Flavonoids; D017382:Reactive Oxygen Species; D017392:Thiobarbituric Acid Reactive Substances; D002374:Catalase; D013482:Superoxide Dismutase; D000252:Calcium-Transporting ATPases; D005978:Glutathione; D018038:Sodium Selenite; D002118:Calcium
Bull World Health Organ. 2001;79(3):249-56
11285671
Surv Ophthalmol. 2008 Jul-Aug;53(4):359-67
18572053
J Ocul Pharmacol Ther. 2009 Oct;25(5):395-400
19857100
Exp Eye Res. 2009 Mar;88(3):575-82
19094987
Exp Eye Res. 2002 Nov;75(5):583-90
12457870
Zhonghua Yan Ke Za Zhi. 2000 Sep;36(5):344-7, 21
11853625
Anal Biochem. 1968 Oct 24;25(1):192-205
4973948
Mol Vis. 2009 Dec 04;15:2570-7
20011628
Am J Clin Nutr. 1996 Nov;64(5):761-6
8901798
Free Radic Biol Med. 2010 Feb 15;48(4):483-92
19932168
Methods Enzymol. 1984;105:121-6
6727660
Exp Eye Res. 2004 Dec;79(6):913-8
15642329
J Ethnopharmacol. 2003 Aug;87(2-3):199-206
12860308
Curr Eye Res. 2007 Nov;32(11):961-71
18027172
Mol Vis. 1997 Jul 23;3:8
9238097
Chem Biol Interact. 2010 Mar 30;184(3):346-51
20067779
Chem Biol Interact. 2009 Oct 7;181(2):202-9
19481068
Curr Eye Res. 2010 Feb;35(2):122-9
20136422
Mol Vis. 2007 Jul 12;13:1121-9
17653057
Exp Eye Res. 2000 Aug;71(2):195-207
10930324
Acta Pharmacol Sin. 2004 Oct;25(10):1250-6
15456524
Invest Ophthalmol Vis Sci. 1989 Jan;30(1):171-5
2912910
Curr Eye Res. 2006 Jan;31(1):1-11
16421014
Exp Eye Res. 2008 Feb;86(2):251-9
18068705
Mol Vis. 2006 Jun 22;12:712-24
16807531
Methods Enzymol. 1974;32:303-6
4280488
J Pharm Pharmacol. 1999 Dec;51(12):1435-40
10678500
Proc Natl Acad Sci U S A. 1996 May 14;93(10):5116-21
8643537
Exp Eye Res. 2009 May;88(5):938-44
19150348
Eur J Biochem. 1968 Oct 17;6(1):126-30
4387188
Indian J Biochem Biophys. 1984 Apr;21(2):130-2
6490072
Curr Eye Res. 2010 Feb;35(2):99-107
20136419
J Biol Chem. 1951 Nov;193(1):265-75
14907713
Phytother Res. 2006 Dec;20(12):1091-5
17009203
Toxicol Appl Pharmacol. 1984 Jun 15;74(1):109-15
6729815
Free Radic Biol Med. 1999 Jul;27(1-2):177-85
10443934
J Hepatol. 1996 Jul;25(1):28-36
8836898